Nutritional Supplementation Would Be Cost-Effective for Reducing Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) Model.
Health Economics
India
nutritional supplementation
tuberculosis
undernutrition
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
10 09 2022
10 09 2022
Historique:
received:
20
06
2021
pubmed:
16
12
2021
medline:
14
9
2022
entrez:
15
12
2021
Statut:
ppublish
Résumé
Undernutrition is the leading cause of tuberculosis (TB) in India and is associated with increased TB mortality. Undernutrition also decreases quality of life and economic productivity. We assessed the cost-effectiveness of providing augmented rations to undernourished Indians through the government's Targeted Public Distribution System (TPDS). We used Markov state transition models to simulate disease progression and mortality among undernourished individuals in 3 groups: general population, household contacts (HHCs) of people living with TB, and persons living with human immunodeficiency virus (HIV). The models calculate costs and outcomes (TB cases, TB deaths, and disability-adjusted life years [DALYs]) associated with a 2600 kcal/day diet for adults with body mass index (BMI) of 16-18.4 kg/m2 until they attain a BMI of 20 kg/m2 compared to a status quo scenario wherein TPDS rations are unchanged. We employed deterministic and probabilistic sensitivity analyses to test result robustness. Over 5 years, augmented rations could avert 81% of TB cases and 88% of TB deaths among currently undernourished Indians. Correspondingly, this intervention could forestall 78% and 48% of TB cases and prevent 88% and 70% of deaths among undernourished HHCs and persons with HIV, respectively. Augmented rations resulted in 10-fold higher resolution of undernutrition and were highly cost-effective with (incremental cost-effectiveness ratio [ICER] of $470/DALY averted). ICER was lower for HHCs ($360/DALY averted) and the HIV population ($250/DALY averted). A robust nutritional intervention would be highly cost-effective in reducing TB incidence and mortality while reducing chronic undernutrition in India.
Sections du résumé
BACKGROUND
Undernutrition is the leading cause of tuberculosis (TB) in India and is associated with increased TB mortality. Undernutrition also decreases quality of life and economic productivity.
METHODS
We assessed the cost-effectiveness of providing augmented rations to undernourished Indians through the government's Targeted Public Distribution System (TPDS). We used Markov state transition models to simulate disease progression and mortality among undernourished individuals in 3 groups: general population, household contacts (HHCs) of people living with TB, and persons living with human immunodeficiency virus (HIV). The models calculate costs and outcomes (TB cases, TB deaths, and disability-adjusted life years [DALYs]) associated with a 2600 kcal/day diet for adults with body mass index (BMI) of 16-18.4 kg/m2 until they attain a BMI of 20 kg/m2 compared to a status quo scenario wherein TPDS rations are unchanged. We employed deterministic and probabilistic sensitivity analyses to test result robustness.
RESULTS
Over 5 years, augmented rations could avert 81% of TB cases and 88% of TB deaths among currently undernourished Indians. Correspondingly, this intervention could forestall 78% and 48% of TB cases and prevent 88% and 70% of deaths among undernourished HHCs and persons with HIV, respectively. Augmented rations resulted in 10-fold higher resolution of undernutrition and were highly cost-effective with (incremental cost-effectiveness ratio [ICER] of $470/DALY averted). ICER was lower for HHCs ($360/DALY averted) and the HIV population ($250/DALY averted).
CONCLUSIONS
A robust nutritional intervention would be highly cost-effective in reducing TB incidence and mortality while reducing chronic undernutrition in India.
Identifiants
pubmed: 34910141
pii: 6462896
doi: 10.1093/cid/ciab1033
pmc: PMC9464065
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
577-585Subventions
Organisme : NIAID NIH HHS
ID : P30 AI042853
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI052074
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Déclaration de conflit d'intérêts
Potential conflicts of interest. L. M. L. reports Thrasher Research Fund Early Career award to study anemia in India. C. R. H. reports being a consultant for Otsuka Pharmaceuticals (no fees received to date); being on the DSMB for the BEAT-TUBERCULOSIS Study, the SUDOCU Study, and the Stool4TB study (all unpaid); and is the Vice-President of the International Union Against Tuberculosis and Lung Disease. N.S.H. reports being on American Society of Tropical Medicine and Hygiene, Respiratory Diseases and Tuberculosis Working Group, Scientific Program Committee. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Références
PLoS One. 2011;6(6):e20755
pubmed: 21738585
Bull World Health Organ. 1959;21(1):51-144
pubmed: 20604054
Int J Tuberc Lung Dis. 2016 Jan;20(1):85-92
pubmed: 26688533
Lancet. 2008 Jan 26;371(9609):340-57
pubmed: 18206223
PLoS One. 2020 Apr 1;15(4):e0229716
pubmed: 32236106
Popul Stud (Camb). 1975 Nov;29(3):391-422
pubmed: 11630508
Epidemiol Health. 2019;41:e2019050
pubmed: 31962037
PLoS One. 2015 Dec 15;10(12):e0144244
pubmed: 26669737
BMJ Open. 2019 Dec 29;9(12):e033158
pubmed: 31888934
Int J Epidemiol. 2010 Feb;39(1):149-55
pubmed: 19820104
BMC Infect Dis. 2019 Oct 29;19(1):914
pubmed: 31664933
Am J Clin Nutr. 2004 Aug;80(2):460-5
pubmed: 15277171
J Infect Dis. 2019 Apr 16;219(9):1356-1363
pubmed: 30476125
PLoS One. 2018 Jul 6;13(7):e0200150
pubmed: 29979738
Am J Epidemiol. 2012 Sep 1;176(5):409-22
pubmed: 22791739
JAMA. 2016 Sep 13;316(10):1093-103
pubmed: 27623463
Clin Infect Dis. 2008 Mar 15;46(6):946-9
pubmed: 18279043
Cureus. 2021 Jan 12;13(1):e12645
pubmed: 33585131
Int J Tuberc Lung Dis. 2011 Jul;15(7):871-85
pubmed: 21496360
N Engl J Med. 2013 Oct 31;369(18):1715-25
pubmed: 24171517
Indian J Tuberc. 2018 Jul;65(3):208-217
pubmed: 29933862
Am J Trop Med Hyg. 1992 Jul;47(1 Pt 2):28-35
pubmed: 1632474
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Eur Respir J. 2013 Jan;41(1):140-56
pubmed: 22936710
BMC Infect Dis. 2021 Oct 12;21(1):1058
pubmed: 34641820
Thorax. 2018 Aug;73(8):702-703
pubmed: 29674388